Botulism: Update and Review

Botulism is both an old and an emerging disease. Over 100 years ago, the classic food-borne type was found to be caused by ingesting contaminated food containing the toxin produced by a bacteria. In the first half of the 20th century a second form, wound botulism, was discovered. Three additional forms (infant, hidden, and inadvertent) were first described in the last quarter of the 20th century. Our understanding of how botulinum toxin blocks the release of acetylcholine at the neuromuscular junction has been clarified in the past 10 years. In the past 20 years, we have witnessed one of the strangest of all ironies in the history of medicine. The very lethal botulinum toxin is now being used as a treatment in an expanding list of disorders. Research is advancing in several directions. These new avenues include improved methods of preventing and treating botulism and additional novel uses of botulinum toxin as a therapeutic agent. In this article, the five clinical forms of botulism, the actions of botulinum toxins, electrodiagnostic methods, treatments, and possible future directions are discussed.

KEYWORDS

Botulism - botulinum toxin - acetylcholine - paralysis - electrodiagnosis - antitoxin - new forms

REFERENCES

• 1 Cherington M. Clinical spectrum of botulism.  Muscle Nerve. 1998;  21 701-710
• 2 Scott A B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.  J Pediatr Ophthalmol Strabismus. 1980;  17 21-25
• 3 Chang M, Glynn K, Groseclose S L. Endemic, notifiable bioterrorism-related diseases, Unites States 1992-1999.  Emerg Infect Dis. 2003;  9 556-564
• 4 Han S Z, Alfano M C, Psoter W J, Rekow E D. Bioterrorism and catastrophe response.  J Am Dent Assoc. 2003;  134 745-752
• 5 Lamanna C. The most poisonous poison.  Science. 1959;  130 763-772
• 6 Burningham M D, Walter F G, Mechem C et al.. Wound botulism.  Ann Emerg Med. 1994;  24 1184-1187
• 7 Hughes J M. Botulism. In: Scheid WM, Whitley RJ, Durack DT Infections of the Central Nervous System. New York; Raven Press 1991: 150-153
• 8 Schantz E J, Johnson E A. Botulinum toxin: the story of its development for the treatment of human disease.  Perspect Biol Med. 1997;  40 317-327
• 9 Foran P G, Davletov B, Meunier F A. Getting muscles moving again after botulinum toxin: novel therapeutic challenges.  Trends Mol Med. 2003;  9 291-298
• 10 Maselli R A. Pathogenesis of human botulism.  Ann N Y Acad Sci. 1998;  841 122-139
• 11 Schiavo G, Benfenati F, Poulain B et al.. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.  Nature. 1992;  359 832-835
• 12 Barnes M. Botulinum toxin: mechanisms of action and clinical use in spasticity.  J Rehabil Med. 2003;  41(suppl) 56-59
• 13 Cherington M. Botulism: ten year experience.  Arch Neurol. 1974;  30 432-437
• 14 Woodruff B A, Griffin P M, McCroskey L M et al.. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States 1975-1988.  J Infect Dis. 1992;  166 1281-1286
• 15 Beller M. Available at: www.phppo.cdc.gov/phtn/botulism/alaska/alaska.asp Accessed 2003
• 16 Townes J M, Cieslak P R, Hatheway C L et al.. An outbreak of type A botulism associated with a commercial cheese sauce.  Ann Intern Med. 1996;  125 558-563
• 17 Shapiro R L, Hatheway C, Becher J, Swerdlow D L. Botulism surveillance and emergency response.  JAMA. 1997;  278 433-435
• 18 Hayes M T, Soto O, Ruoff K L. Case records of the Massachusetts General Hospital: case 22-1997.  N Engl J Med. 1997;  337 184-190
• 19 Angulo F J, Getz J, Taylor J P et al.. A large outbreak of botulism: the hazardous baked potato.  J Infect Dis. 1998;  178 172-177
• 20 Brown L W. Infant botulism.  Adv Pediatr. 1981;  28 141-157
• 21 Goode G B, Shearn D L. Botulism. A case with associated sensory abnormalities.  Arch Neurol. 1982;  39 55
• 22 Kuruoglu R, Cengiz B, Tokcaer A. Botulism with sensory symptoms diagnosed by neuromuscular transmission studies associated with edrophonium responsiveness.  Electromyogr Clin Neurophysiol. 1996;  36 477-480
• 23 Martinez-Castrillo J D, Del Real M A, Hernandex Gonzalez A et al.. Botulism with sensory symptoms: a second case.  J Neurol Neurosurg Psychiatry. 1991;  54 844-845
• 24 Girlanda P, Vita G, Nicolosi C et al.. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.  J Neurol Neurosurg Psychiatry. 1992;  55 844-845
• 25 Jenzer G, Mumenthaler M, Ludin H P, Robert F. Autonomic dysfunction in botulism B: a clinical report.  Neurology. 1975;  25 150-153
• 26 Chen J T, Chen C C, Lin K P et al.. Botulism: heart rate variation, sympathetic skin responses, and plasma norepinephrine.  Can J Neurol Sci. 1999;  26 123-126
• 27 Duchen L W, Strich S J. The effects of botulism toxin on the pattern of innervation of skeletal muscle in the mouse.  Q J Exp Physiol Cogn Med Sci. 1968;  53 84-89
• 28 Eleopra R, Tugnoli V, Rossetto O et al.. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.  Neurosci Lett. 1998;  256 135-138
• 29 Uncini A, Lugarosi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block.  Muscle Nerve. 1999;  22 640-644
• 30 Shapiro B E, Soto O, Shafqat S, Blumenfeld H. Adult botulism.  Muscle Nerve. 1997;  20 100-102
• 31 Cherington M. Electrophysiologic methods as an aid in diagnosis of botulism: a review.  Muscle Nerve. 1982;  5 S28-S29
• 32 Ryan D W, Cherington M. Human type A botulism.  JAMA. 1971;  216 513-514
• 33 Edell T A, Sullivan C P, Osborn K M et al.. Wound botulism associated with a positive tensilon test.  West J Med. 1983;  139 218-219
• 34 Pickett J B, Berg B, Chaplin E, Brunstetter-Shafer M A. Syndrome of botulism in infancy: clinical and electrophysiologic study.  N Engl J Med. 1976;  295 770-772
• 35 Arnon S S. Infant botulism: anticipating the second decade.  J Infect Dis. 1986;  154 201-205
• 36 Schmidt R D, Schmidt T W. Infant botulism: a case series and review of the literature.  J Emerg Med. 1992;  10 713-718
• 37 Kothare S V, Kassner E G. Infant botulism: a rare cause of colonic ileus.  Pediatr Radiol. 1995;  25 24-26
• 38 Tanki M G, Gabay M P. Association between honey consumption and infant botulism.  Pharmacotherapy. 2002;  22 1479-1483
• 39 Ravid S, Maytal J, Eviatar L. Biphasic course of infant botulism.  Pediatr Neurol. 2000;  23 338-340
• 40 Schechter R. Infant botulism: a brief overview.  Anaerobe. 1999;  5 161-164
• 41 Underwook K, Deakers T W, Newth C J, Mitchell W G. Infant botulism: a 26-year experience in the pediatric intensive care unit.  Crit Care Med. 2003;  31(suppl) , Abstract 531
• 42 Bennett A M, Perkins S D, Holley J L. DNA vaccination protects against botulinum neurotoxin F.  Vaccine. 2003;  21 3110-3117
• 43 Midura T F. Update: infant botulism.  Clin Microbiol Rev. 1996;  9 119-125
• 44 Armada M, Love S, Barrett E et al.. Foodborne botulism in a six-month old infant caused by home-canned baby food.  Ann Emerg Med. 2003;  42(2) 226-229
• 45 MacDonald K L, Rutherford G W, Friedman S M et al.. Botulism and botulism-like illness in chronic drug abusers.  Ann Intern Med. 1985;  102 616-618
• 46 Mandler R N, Maselli R A. Stimulated single-fiber electromyography in wound botulism.  Muscle Nerve. 1996;  19 1171-1173
• 47 Chang G Y, Ganguly G. Early antitoxin treatment in wound botulism results in better outcome.  Eur Neurol. 2003;  49 151-153
• 48 Kudrow D B, Henry D A, Haska D A et al.. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse.  Ann Intern Med. 1988;  109 984-985
• 49 Cherington M. Treatment of botulism and wound botulism. In: Balows A, DeHaan RM, Dowell VR, Guze LB Anaerobic Bacteria: Role in Disease. Springfield; Charles C. Thomas 1974: 287-294
• 50 Park J-B, Simpson L L. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component.  Infect Immun. 2003;  71 1147-1154
• 51 Cherington M. Botulism.  Semin Neurol. 1990;  10 27-31
• 52 Technical Briefs . Botulism: information from the World Health Organization.  J Environ Health. 2003;  65 51-52
• 53 Chia J K, Clark J G, Ryan C A, Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum .  N Engl J Med. 1986;  315 239-241
• 54 Kobayashi H, Fujisawa K, Saito Y et al.. A botulism case of a 12-year-old girl caused by intestinal colonization of Clostridium botulinum type Ab.  Jpn J Infect Dis. 2003;  56 73-74
• 55 Bakheit A M, Ward C D, McLellan D L. Generalised botulism-like syndrome after intramuscular injections of botulinum type A: a report of two cases.  J Neurol Neurosurg Psychiatry. 1997;  62 198
• 56 Bhatia K P, Munchau A, Thompson P D et al.. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.  J Neurol Neurosurg Psychiatry. 1999;  67 90-93
• 57 Tugnoli V, Eleopra R, Quatrale R et al.. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis.  Br J Dermatol. 2002;  147 808-809
• 58 Girlanda P, Vita G, Nicolosi C et al.. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.  J Neurol Neurosurg Psychiatry. 1992;  55 844-845
• 59 Lange D J, Brin M F, Warner C L et al.. Distant effects of local injection of botulinum toxin.  Muscle Nerve. 1987;  10 552-555
• 60 Olney R K, Aminoff M J, Gelb D J, Lowenstein D H. Neuromuscular effects distant from the site of botulinum neurotoxin injections.  Neurology. 1988;  38 1780-1783
• 61 Kessler K R, Skutta M, Benecke R. Long term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency.  J Neurol. 1999;  246 265-274
• 62 Ross M H, Charness M E, Sudarsky L, Logigian E L. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles.  Muscle Nerve. 1997;  20 593-598
• 63 Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.  Eur Neurol. 2003;  49 34-38
• 64 Dowell V R, McCrosky L M, Hatheway C L et al.. Coproexamination for botulium toxin and Clostridium botulinum .  JAMA. 1977;  238 1829-1832
• 65 Cornblath D R, Sladky J T, Sumner A J. Clinical electrophysiology of infantile botulism.  Muscle Nerve. 1983;  6 448-452
• 66 Gutmann L, Bodensteiner J, Gutierrez A. Electrodiagnosis of botulism.  J Pediatr. 1992;  121 835
• 67 Fakadej A V, Gutmann L. Prolongation of post-tetanic facilitation in infant botulism.  Muscle Nerve. 1982;  5 727-729
• 68 Girlanda P, Dattola R, Messina C. Single fibre EMG in 6 cases of botulism.  Acta Neurol Scand. 1983;  67 118-123
• 69 Schiller H H, Stalberg E. Human botulism studied with single-fiber electromyography.  Arch Neurol. 1978;  35 346-349
• 70 Hughes J M, Tacket C O. “Sausage poisoning” revisited.  Arch Intern Med. 1983;  143 425-427
• 71 Atabek M E, Yavuz H, Oran B et al.. Plasmapheresis as an adjunct treatment in severe botulism.  Intensive Care Med. 2002;  28 814
• 72 Robinson R F. Management of botulism.  Ann Pharmacother. 2003;  37 127-131
• 73 Vahdani P, Pourshafie M R, Aminzadeh Z. Treatment of two unusual cases of type A and E botulism following consumption of salted fish.  Intensive Care Med. 2002;  28 1189
• 74 Amersdorfer P, Wong C, Smith T et al.. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.  Vaccine. 2002;  20 1640-1648
• 75 Nowakowski A, Wang C, Powers D B et al.. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.  Proc Natl Acad Sci USA. 2002;  99 11346-11350
• 76 Cherington M. Botulism. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE Neuromuscular Disorders in Clinical Practice. Boston; Butterworth Heinemann 2002: 942-952
• 77 Jankovic J, Vuong M A, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.  Neurology. 2003;  60 1186-1188
• 78 Dodick D W. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.  Headache. 2003;  43 S25-S33
• 79 Rohrich R J. Completing the cosmetic surgery cycles: it takes a village.  Plast Reconstr Surg. 1999;  103 585-587
• 80 Vaezi M F, Richter J E, Wilcox C M et al.. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial.  Gut. 1999;  44 231-239
• 81 Brisinda G, Maria G, Bentivoglo A R et al.. A comparison of injection of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure.  N Engl J Med. 1999;  341 65-69
• 82 Maria G, Brisinda G, Civello I M et al.. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.  Urology. 2003;  62 259-265
• 83 Hallett M. One man's poison: clinical applications of botulinum toxin.  N Engl J Med. 1999;  341 118-120
• 84 Eleopra R, Tugnoli V, Quatrale R et al.. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.  Clin Neurophysiol. 2002;  113 1258-1264
• 85 Brashear A, McAfee A L, Kuhn E R, Ambrosius W T. Treatment with botulinum toxin type B for upper-limb spasticity.  Arch Phys Med Rehabil. 2003;  84 103-107
• 86 Turton K, Chaddock J A, Acharya K R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.  Trends Biochem Sci. 2002;  27 552-558